MAGGIE ZIEBOLD: Open Payments
NPI 1710426929 · BUFFALO, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,042 in 14 payments from 9 companies in 2025. Trend: 2023 $260 · 2024 $439 · 2025 $1,042
Food & beverage: $669Travel & lodging: $373
| Company | Payments | Amount |
|---|---|---|
| Microtransponder, Inc. | 2 | $735 |
| Merz Pharmaceuticals, LLC | 3 | $97 |
| ABBVIE INC. | 2 | $53 |
| Neurocrine BioSciences, Inc. | 2 | $39 |
| Mallinckrodt Hospital Products Inc. | 1 | $35 |
| Janssen Biotech, Inc. | 1 | $24 |
| AstraZeneca Pharmaceuticals LP | 1 | $22 |
| SK Life Science, Inc. | 1 | $20 |
| LivaNova USA, Inc. | 1 | $18 |
Products named: Xeomin, INGREZZA, ACTHAR, UBRELVY, BOTOX, WAINUA, VNS THERAPY SENTIVA MODEL 1000 GENERATOR.
Industry payments across NY — which companies pay providers there.
